002370 Stock Overview
Researches, produces, sells, and exports pharmaceutical products in China and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Zhejiang Yatai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥3.34 |
52 Week High | CN¥5.17 |
52 Week Low | CN¥2.21 |
Beta | 0.47 |
11 Month Change | 6.03% |
3 Month Change | 22.34% |
1 Year Change | -33.73% |
33 Year Change | -21.41% |
5 Year Change | -46.82% |
Change since IPO | -79.61% |
Recent News & Updates
Recent updates
Shareholder Returns
002370 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 0.9% | -1.5% | -2.1% |
1Y | -33.7% | -9.4% | 2.8% |
Return vs Industry: 002370 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.
Return vs Market: 002370 underperformed the CN Market which returned 5.4% over the past year.
Price Volatility
002370 volatility | |
---|---|
002370 Average Weekly Movement | 8.2% |
Pharmaceuticals Industry Average Movement | 7.3% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 12.6% |
10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002370 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002370's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1989 | 528 | Jianwei Cen | www.ytyaoye.com |
Zhejiang Yatai Pharmaceutical Co., Ltd. researches, produces, sells, and exports pharmaceutical products in China and internationally. The company offers tablets, capsules, patches, powder injections, freeze-dried powders, and troches. It also provides pharmaceutical research and development services.
Zhejiang Yatai Pharmaceutical Co., Ltd. Fundamentals Summary
002370 fundamental statistics | |
---|---|
Market cap | CN¥2.09b |
Earnings (TTM) | -CN¥16.60m |
Revenue (TTM) | CN¥425.62m |
4.9x
P/S Ratio-125.8x
P/E RatioIs 002370 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
002370 income statement (TTM) | |
---|---|
Revenue | CN¥425.62m |
Cost of Revenue | CN¥300.05m |
Gross Profit | CN¥125.57m |
Other Expenses | CN¥142.17m |
Earnings | -CN¥16.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.027 |
Gross Margin | 29.50% |
Net Profit Margin | -3.90% |
Debt/Equity Ratio | 97.0% |
How did 002370 perform over the long term?
See historical performance and comparison